Bayesian Capital Management, LP Alnylam Pharmaceuticals, Inc. Transaction History

Bayesian Capital Management, LP

  • $838 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$169.75 - $207.73 $288,575 - $353,141
-1,700 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$128.63 - $176.89 $218,671 - $300,713
1,700 New
1,700 $288,000
Q4 2018

Feb 13, 2019
SELL
$62.67 - $88.33 $313,350 - $441,650
-5,000 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$87.52 - $122.67 $437,600 - $613,350
5,000 New
5,000 $438,000

Others Institutions Holding ALNY

# of Institutions
644
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $31.3B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email